Encinitas, CA, United States of America

Wendy Johnson


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 73(Granted Patents)


Company Filing History:


Years Active: 2000-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Wendy Johnson

Introduction

Wendy Johnson, an accomplished inventor based in Encinitas, CA, has made significant strides in the field of biotechnology. With a total of three patents to her name, she exemplifies the spirit of innovation and commitment to advancing therapeutic methods through her work.

Latest Patents

Wendy's latest patents focus on receptor-mediated gene delivery using bacteriophage vectors. These innovations leverage filamentous phage particles that display a ligand on their surface, aimed at delivering therapeutic genes efficiently to target cells. The ligand itself is a fusion protein that is either covalently conjugated to the phage particles or complexed with modified phage particles, showcasing her ingenuity in genetic engineering.

Career Highlights

As an integral member of Selective Genetics, Inc., Wendy has contributed greatly to the development of pioneering biotechnological solutions. Her work not only pushes the boundaries of gene therapy but also reflects her dedication to improving the health outcomes for patients. Her career is marked by a determination to facilitate novel approaches in medical treatments.

Collaborations

Wendy collaborates with talented professionals, including David Larocca and Andrew J. Baird. Together, they create a rich environment of knowledge sharing and innovation, which propels their collective work forward. Such collaborations are vital in fostering creativity and enhancing the impact of their research.

Conclusion

In summary, Wendy Johnson stands out as a prominent figure in innovation, particularly in the realm of biotechnology. With her groundbreaking patents and collaborative spirit, she continues to make waves in the field, paving the way for future advancements in genetic therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…